24 results
DEFM14A
LABP
Landos Biopharma Inc
25 Apr 24
Proxy related to merger
5:07pm
a condition to the obligations of Parent and Landos to effect the Closing;
there is voluntary commitment or agreement with the U.S. Department of Justice … and interest. The Treasury Department has released proposed regulations which, if finalized in their present form, would eliminate the federal withholding
PREM14A
LABP
Landos Biopharma Inc
15 Apr 24
Preliminary proxy related to merger
5:18pm
to effect the Closing;
there is voluntary commitment or agreement with the U.S. Department of Justice (“DOJ”) or U.S. Federal Trade Commission (“FTC … these requirements. FATCA withholding currently applies to payments of dividends and interest. The Treasury Department has released proposed
DEFA14A
LABP
Landos Biopharma Inc
25 Mar 24
Additional proxy soliciting materials
9:19am
on, any list of sanctioned parties maintained by the United States, including the list of U.S. Department of the Treasury’s Office of Foreign Assets … and the Rights Agent, in substantially the form attached hereto as EXHIBIT D (subject to changes permitted by Section 5.17).
“DOJ” means the U.S. Department
8-K
EX-2.1
LABP
Landos Biopharma Inc
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
maintained by the United States, including the list of U.S. Department of the Treasury’s Office of Foreign Assets Control’s List of Specially … the form attached hereto as EXHIBIT D (subject to changes permitted by Section 5.17).
“DOJ” means the U.S. Department of Justice.
A-4
“Employee Plan
8-K
5w2bk47o 142dc
10 Nov 21
Departure of Directors or Certain Officers
4:49pm
10-K
3ifmrd oyzps
31 Mar 21
Annual report
5:03pm
424B4
82zxhs2zgba8fq5
4 Feb 21
Prospectus supplement with pricing info
5:02pm
S-1/A
5zs1g1nrwik
28 Jan 21
IPO registration (amended)
9:12am
S-1/A
EX-1.1
ebb mdned
28 Jan 21
IPO registration (amended)
9:12am
S-1/A
EX-10.5
gbn1q 6hnusr7ww
28 Jan 21
IPO registration (amended)
9:12am